About Nobilis Health Corp. (NYSEAMERICAN:HLTH)
Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company's segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers. The Marketing Services segment provides marketing services, patient education services and patient care co-ordination management services. The Company provides care across a range of specialties in its facilities, including orthopedic surgery, podiatric surgery, pain management, gastro-intestinal, gynecology, and general surgery. Many of its surgical patients require additional complementary healthcare services, and its suite of ancillary services, including surgical assist, intraoperative neuromonitoring and anesthesia.
Industry, Sector and Symbol:
- Industry: Healthcare Facilities & Services
- Sub-Industry: N/A
- Sector: N/A
- Symbol: NYSEAMERICAN:HLTH
- Previous Symbol: NYSE:HLTH
- CUSIP: N/A
- Web: www.northstar-healthcare.com
- Outstanding Shares: 77,810,000
Frequently Asked Questions for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
What is Nobilis Health Corp.'s stock symbol?
Nobilis Health Corp. trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "HLTH."
How will Nobilis Health Corp.'s stock buyback program work?
Nobilis Health Corp. announced that its board has authorized a share buyback program on Wednesday, November 15th 2017, which allows the company to repurchase 4,000,000 outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
How were Nobilis Health Corp.'s earnings last quarter?
Nobilis Health Corp. (NYSEAMERICAN:HLTH) announced its quarterly earnings results on Monday, November, 6th. The healthcare company reported $0.01 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.03. The healthcare company had revenue of $64.70 million for the quarter, compared to analyst estimates of $78.29 million. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period last year, the business earned ($0.04) earnings per share. View Nobilis Health Corp.'s Earnings History.
When will Nobilis Health Corp. make its next earnings announcement?
Where is Nobilis Health Corp.'s stock going? Where will Nobilis Health Corp.'s stock price be in 2017?
3 Wall Street analysts have issued 1 year price targets for Nobilis Health Corp.'s shares. Their forecasts range from $2.00 to $2.50. On average, they anticipate Nobilis Health Corp.'s stock price to reach $2.25 in the next twelve months. View Analyst Ratings for Nobilis Health Corp..
Are investors shorting Nobilis Health Corp.?
Nobilis Health Corp. saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 3,137,212 shares, a drop of 10.0% from the October 13th total of 3,486,276 shares. Based on an average daily volume of 212,492 shares, the days-to-cover ratio is presently 14.8 days. Currently, 5.6% of the shares of the stock are short sold.
Who are some of Nobilis Health Corp.'s key competitors?
Some companies that are related to Nobilis Health Corp. include Evolution Petroleum Corp (EPM), VirnetX Holding Corp (VHC), Majesco (MJCO), Great Panther Silver Limited (GPL), Polymet Mining Corp (PLM), Ashford (AINC), Gastar Exploration (GST), Palatin Technologies (PTN), Libbey (LBY), Asanko Gold (AKG), Delta Apparel (DLA), Americas Silver (USAS), Alio Gold (ALO), Orchids Paper Products Company (TIS), BG Staffing (BGSF), CRH Medical (CRHM), Alexco Resource Corp. (AXU) and OncoCyte Corp (OCX).
Who owns Nobilis Health Corp. stock?
Nobilis Health Corp.'s stock is owned by a variety of of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (73,425,100.00%) and Macquarie Group Ltd. (49,863,300.00%). Company insiders that own Nobilis Health Corp. stock include Donald Louis Kramer, Harry Joseph Fleming, Jennifer Hauser, Kenneth Efird, Kenneth Joseph Klein, Marcos Alberto Rodriguez, Matthew Keavney Maruca, Paul David Young, Peter Horan and Richard Ganley. View Institutional Ownership Trends for Nobilis Health Corp..
Who bought Nobilis Health Corp. stock? Who is buying Nobilis Health Corp. stock?
Nobilis Health Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Macquarie Group Ltd.. Company insiders that have bought Nobilis Health Corp. stock in the last two years include Donald Louis Kramer, Harry Joseph Fleming, Jennifer Hauser, Kenneth Efird, Kenneth Joseph Klein, Marcos Alberto Rodriguez, Matthew Keavney Maruca, Paul David Young, Peter Horan and Richard Ganley. View Insider Buying and Selling for Nobilis Health Corp..
How do I buy Nobilis Health Corp. stock?
Shares of Nobilis Health Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nobilis Health Corp.'s stock price today?
One share of Nobilis Health Corp. stock can currently be purchased for approximately $1.45.
How big of a company is Nobilis Health Corp.?
Nobilis Health Corp. has a market capitalization of $112.82 million.
How can I contact Nobilis Health Corp.?
Nobilis Health Corp.'s mailing address is 11700 Katy Fwy Ste 300, HOUSTON, TX 77079-1218, United States. The healthcare company can be reached via phone at +1-713-3558614.
MarketBeat Community Rating for Nobilis Health Corp. (NYSEAMERICAN HLTH)MarketBeat's community ratings are surveys of what our community members think about Nobilis Health Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Nobilis Health Corp. (NYSEAMERICAN:HLTH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 2 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.33)|
|Consensus Price Target: ||$2.25|
Consensus Price Target History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
Analysts' Ratings History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
(Data available from 11/19/2015 forward)
|5/19/2017||Benchmark Co.||Initiated Coverage||Buy -> Buy||$2.50|
|3/13/2017||Pi Financial||Downgrade||Buy -> Neutral|
|12/12/2016||Craig Hallum||Downgrade||Buy -> Hold||$6.00 -> $2.00|
|9/19/2016||Canaccord Genuity||Set Price Target||Buy||$4.80|
Earnings History and Estimates Chart for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
Earnings History by Quarter for Nobilis Health Corp. (NYSEAMERICAN HLTH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/12/2018|| || || || || || || || |
|11/6/2017||Q3 2017||$0.04||$0.01||$78.29 million||$64.70 million||View||N/A|
|8/2/2017||Q2 2017||$0.01||$0.02||$69.89 million||$79.96 million||View||Listen|
|5/2/2017||Q1 2017||($0.10)||($0.02)||$56.30 million||$68.30 million||View||Listen|
|3/13/2017||Q4 2016||$0.36||$0.12||$100.11 million||$101.90 million||View||N/A|
|11/7/2016||Q316||$0.07||($0.04)||$65.75 million||$70.70 million||View||Listen|
|8/2/2016||Q216||$0.01||$0.06||$62.18 million||$61.90 million||View||N/A|
|8/14/2015||Q215||($0.03)||($0.02)||$42.20 million||$48.90 million||View||N/A|
Earnings Estimates for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Nobilis Health Corp. (NYSEAMERICAN HLTH)
Insider Trades by Quarter for Nobilis Health Corp. (NYSEAMERICAN HLTH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/26/2017||Paul David Young||CFO||Buy||10,000||$1.40||$14,000.00|| |
|3/23/2017||Harry Joseph Fleming||CEO||Buy||25,000||$1.69||$42,250.00|| |
|3/21/2017||Harry Joseph Fleming||CEO||Buy||25,000||$1.75||$43,750.00|| |
|3/17/2017||Harry Joseph Fleming||CEO||Buy||25,000||$1.70||$42,500.00|| |
|3/17/2017||Marcos Alberto Rodriguez||Insider||Buy||3,500||$1.70||$5,950.00|| |
|12/20/2016||Peter Horan||Director||Buy||5,000||$1.90||$9,500.00|| |
|2/16/2016||Donald Louis Kramer||Major Shareholder||Buy||20,000||$2.08||$41,600.00|| |
|2/12/2016||Donald Louis Kramer||Major Shareholder||Buy||20,000||$1.97||$39,400.00|| |
|2/4/2016||Harry Joseph Fleming||CEO||Buy||10,000||$2.38||$23,800.00|| |
|2/3/2016||Harry Joseph Fleming||CEO||Buy||10,000||$2.22||$22,200.00|| |
|2/2/2016||Harry Joseph Fleming||CEO||Buy||10,000||$2.20||$22,000.00|| |
|2/1/2016||Kenneth Joseph Klein||CFO||Buy||5,000||$2.16||$10,800.00|| |
|1/29/2016||Harry Joseph Fleming||CEO||Buy||31,700||$1.99||$63,083.00|| |
|1/29/2016||Jennifer Hauser||Director||Buy||9,137||$1.97||$17,999.89|| |
|1/29/2016||Kenneth Efird||COO||Buy||11,900||$2.08||$24,752.00|| |
|1/29/2016||Matthew Keavney Maruca||Insider||Buy||2,300||$2.07||$4,761.00|| |
|1/26/2016||Jennifer Hauser||Director||Buy||8,700||$2.06||$17,922.00|| |
|1/22/2016||Richard Ganley||Director||Buy||10,000||$2.11||$21,100.00|| |
|9/11/2015||Richard Ganley||Director||Buy||5,000||$4.50||$22,500.00|| |
|8/21/2015||Richard Ganley||Director||Buy||5,300||$4.66||$24,698.00|| |
|6/18/2015||Richard Ganley||Director||Buy||6,000||$6.58||$39,480.00|| |
Latest Headlines for Nobilis Health Corp. (NYSEAMERICAN HLTH)
Nobilis Health Corp. (NYSEAMERICAN HLTH) Chart for Sunday, November, 19, 2017